1. Athirakul, Krairerk, Bradbury, J Alyce, Graves, Joan P, Coffman, Thomas M, Zeldin, Darryl C. 2008. Increased blood pressure in mice lacking cytochrome P450 2J5. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 22, 4096-108. doi:10.1096/fj.08-114413. https://pubmed.ncbi.nlm.nih.gov/18716027/
2. Liu, Yan, Li, Liu, Yi, Bin, Zheng, Li, Zhang, Hao. 2019. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell. In Life sciences, 234, 116755. doi:10.1016/j.lfs.2019.116755. https://pubmed.ncbi.nlm.nih.gov/31415769/
3. Askar, Noor, Jarrar, Yazun, Gharaibeh, Munir, Alqudah, Mohammad. . Upregulation of Beta 1 and Arachidonic Acid Metabolizing Enzymes in the Mouse Hearts and Kidneys after Sub Chronic Administration of Rofecoxib. In Current molecular pharmacology, 16, 381-392. doi:10.2174/1874467215666220413085316. https://pubmed.ncbi.nlm.nih.gov/35422231/
4. Wang, Weicang, Yang, Jun, Qi, Weipeng, Kim, Daeyoung, Zhang, Guodong. 2016. Lipidomic profiling of high-fat diet-induced obesity in mice: Importance of cytochrome P450-derived fatty acid epoxides. In Obesity (Silver Spring, Md.), 25, 132-140. doi:10.1002/oby.21692. https://pubmed.ncbi.nlm.nih.gov/27891824/
5. Wu, Xiaoli. 2019. Candidate genes associated with the effect of rosiglitazone on glycemic control and cardiovascular system in the treatment of type 2 diabetes mellitus. In Experimental and therapeutic medicine, 17, 2039-2046. doi:10.3892/etm.2019.7160. https://pubmed.ncbi.nlm.nih.gov/30783475/